Skip to content
Screener

Erasca, Inc. ERAS Other Income (Expense)

Other Income (Expense) at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$61M+112%
Eli Lilly logo
Eli LillyLLY
$269M+399%
Amgen logo
AmgenAMGN
-$73M+81.5%
Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
-$139.24M-923%
Tango Therapeutics logo
Tango TherapeuticsTNGX
$3.26M+21.1%
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
$10.01M-18.1%

Other financials

Income statement

See full
Operating income-$187.9M-427%
Net income-$183.4M-492%
EPS (diluted)-$0.60-445%

Balance sheet

See full
Cash & equivalents$47.3M-33.0%
Total debt$46.0M-9.6%
Total equity$393.5M-1.5%
Total assets$461.2M-2.1%

Cash flow

See full
Operating cash flow-$27.4M+13.2%
CapEx$36.0K-56.6%
Free cash flow-$27.4M+13.3%

Valuation

See full
Market cap$6.34B+1,424%
Enterprise value$6.34B+1,487%

Returns & leverage

See full
Return on equity-69.9%+77.1pp
Debt / equity0.1×0.0×
Current ratio9.5×-2.8×

Where this comes from

Reported directly by Erasca, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.

The source filing: Erasca, Inc.’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 4:13 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-216788
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Other income (expense)
Interest income4,4494,740
Other income (expense), net22(76)
Total other income (expense), net4,4714,664
Net loss$(183,440)$(30,966)
Net loss per share, basic and diluted$(0.60)$(0.11)
Weighted-average shares of common stock used in computing net loss per share, basic and diluted304,317,460283,260,289
Other comprehensive income (loss):

Item 1. Financial Statements.

FAQ

What is Erasca, Inc.'s other income (expense)?
Erasca, Inc. (ERAS) reported other income (expense) of $4.47M in Q1 2026.
How has Erasca, Inc.'s other income (expense) changed year-over-year?
Erasca, Inc.'s other income (expense) decreased by 4.1% year-over-year, from $4.66M to $4.47M.
What is the long-term trend for Erasca, Inc.'s other income (expense)?
Over 4 years (2021 to 2025), Erasca, Inc.'s other income (expense) has grown at a 66.7% compound annual growth rate (CAGR), from $2.12M to $16.36M.
What does other income (expense) mean?
Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.

Ask your AI about Erasca, Inc.'s other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude